Mes compétences :
Biologie
Santé
Management
Affaires médicales
Organisation et stratégie
Business development
Industrie pharmaceutique
Affaires économiques
Stratégie
Prix et accès au marché
Entreprises
Simon-Kucher & Partners
- Senior Consultante Life Sciences
Avignon2018 - maintenant- Evolution: 4 level promotions in less than 3 years
- Key projects: pricing and market access launch strategy, early clinical value assessment, affiliate preparation to the pricing negotiations with local authorities, business intelligence/ market share analysis/ revenue modelling, etc.
- Scope: Several therapeutic area (e.g., renal cell carcinoma, multiple sclerosis, psoriasis, etc.) in key markets (EU-5, Belgium, US, etc.) for the top 10 pharma companies
- Management: project leading and team management
- Learnings: Pricing and market access research (local database), value and pricing assessment (tools, methodology), presentations to senior management team, international team work
Simon-Kucher & Partners
- Consultante Life Sciences
Avignon2015 - 2018
Roche Pharma France
- Apprentissage ESSEC
Boulogne-Billancourt2013 - 2015- Pipeline Product Strategy Team, Business Development (2014 – 2015)
• Define the Business Strategy and elaborate in-depth analysis on current and future markets
• Collaborate with Market Research, Health Economics, Medical and Marketing teams to provide targeted market intelligence reviews and support local market forecast development
- Medical Affairs Avastin, Breast and Ovarian Cancer (2013 – 2014)
• Medico-marketing strategic thinking, clinical trials and project management (development of an IT tool), medical newsletter
• Participation in the “ESME” project: Real World Data base to defend the place of Avastin in metastatic Breast Cancer towards French Health Authorities
Tumor microenvironment Global Core Research Center - Seoul National University
- Ingénieur d'études
2012 - 2012Effets Chimiopréventifs de l'acide cinnamique, extrait de la plante Cinnamomum cassia
Expérimentation animale
Recherche fondamentale